Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ELI LILLY AND COMPANY

(LLY)
  Rapport
Geschatte realtime Cboe BZX  -  16:41 29-11-2022
362.38 USD   -0.93%
22/11Eli Lilly and Company : Berenberg Bank herhaalt koopadvies
MM
18/11Eli Lilly and Company : Credit Suisse ontvangt een koopadvies
MM
17/11Eli Lilly and Company : Morgan Stanley nog altijd een koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Dagen
:
Uren
:
Minuten
:
Seconden
Communiquťs de presse de la sociťtť ELI LILLY AND COMPANY
16:01Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement
PR
21/11Lilly Announces Details of Presentations at 2022 San Antonio Breast Cancer Symposium
PR
16/11Lilly to Participate in Evercore ISI HealthCONx Conference
PR
07/11Lilly to begin rollout of Tempoģ Personalized Diabetes Management Platform
PR
03/11Akouos Investor Alert By The Former : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
PR
01/11ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
AQ
01/11Eli Lilly And : Q3 2022 Lilly Presentation
PU
01/11Lilly : Q3 Earnings Snapshot
AQ
01/11Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progres..
PR
27/10Lilly commits $92.5 million to Purdue to establish an innovative pharmaceutical manufac..
PR
19/10Lilly Confirms Date and Conference Call for Third-Quarter 2022 Financial Results Announ..
PR
17/10Lilly Declares Fourth-Quarter 2022 Dividend
PR
12/10Eli Lilly & Co : Other Events (form 8-K)
AQ
06/10Lilly receives U.S. FDA Fast Track designation for tirzepatide for the treatment of adu..
PR
22/09FDA Approves Lilly's Retevmoģ (selpercatinib), the First and Only RET Inhibitor for Adu..
PR
20/09Veru Announces FDA has Updated the Meeting Date for the Advisory Committee Meeting to R..
AQ
08/09Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Lilly's Phase ..
PR
08/09Lilly Announces Details of Presentations at ESMO Congress 2022
PR
02/09Eli Lilly And : 2022 CDP Climate Change Report
PU
02/09Eli Lilly And : 2022 CDP Water Security Report
PU
31/08Lilly to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
PR
25/08Lilly to Participate in Citi's 17th Annual BioPharma Conference
PR
17/08Direct Relief Delivers Seven-Week Supply of Long-Acting Insulin to Ukraine, Donated by ..
AQ
11/08Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Offic..
PR
10/08Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs
AQ
08/08Lilly's Taltzģ (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce In..
PR
06/08Biden team, Eli Lilly condemn new Indiana abortion ban
AQ
04/08ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
AQ
04/08Lilly Updates Conference Call Start Time for Second-Quarter 2022 Financial Results
PR
04/08Eli Lilly And : Q2 2022 Financial Workbook
PU
04/08Eli Lilly And : Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New..
PU
04/08Eli Lilly And : Q2 2022 Lilly Press Release
PU
04/08Lilly : Q2 Earnings Snapshot
AQ
04/08Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines an..
PR
21/07Lilly Confirms Date and Conference Call for Second-Quarter 2022 Financial Results Annou..
PR
29/06Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government in ong..
PR
27/06Lilly Declares Third-Quarter 2022 Dividend
PR
10/06Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs
AQ
07/06Eli Lilly And : Lilly Diabetes & Obesity ADA Update Presentation
PU
07/06Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly's Lebrikizumab..
PR
03/06Lilly to Participate in Goldman Sachs Global Healthcare Conference
PR
31/05Lilly to build two new US manufacturing sites
AQ
25/05Lilly plans to invest $2.1 billion in new manufacturing sites in Indiana
PR
24/05Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Cli..
PR
16/05Lilly to Participate in UBS Global Healthcare Conference 2022
PR
06/05Eli Lilly & Co : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
06/05Mary Lynne Hedley Elected to Lilly Board of Directors
PR
04/05Eli Lilly & Co : Material Modification to Rights of Security Holders, Amendments to Articl..
AQ
03/05Lilly to Participate in Bank of America Securities 2022 Healthcare Conference
PR
03/05Eli Lilly announces Q2 2022 dividend
AQ
02/05Lilly Declares Second-Quarter 2022 Dividend
PR
29/04ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
AQ
28/04Eli Lilly And : Q1 2022 Lilly Presentation
PU
28/04Eli Lilly And : Q1 2022 Lilly Press Release
PU
28/04Lilly : Q1 Earnings Snapshot
AQ
28/04Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
PR
28/04Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overwei..
PR
20/04Eli Lilly And : Q4 2021Revised Financial Workbook
PU
20/04Tackling Health Disparities And Ineq : New Program Encourages Black and Latina Women to De..
PR
19/04Lilly Confirms Date and Conference Call for First-Quarter 2022 Financial Results Announ..
PR
14/04Eli Lilly & Co : Results of Operations and Financial Condition (form 8-K)
AQ
12/04Telix Announces Licence Agreement with Lilly for Olaratumab
AQ
11/04Lilly's Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improveme..
PR
01/04Lilly Presents Updated Data on Retevmoģ (selpercatinib) in Advanced RET Fusion-Positive..
PR
28/03Innovent and Lilly Expand Strategic Partnership in Oncology
PR
24/03Lilly Announces Complete Response Letter for Sintilimab in Combination with Pemetrexed ..
PR
23/03Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly
AQ
16/03Jardianceģ phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy i..
PR
03/03Lilly to Participate in Barclays Global Healthcare Conference
PR
28/02Lilly to Participate in Cowen Health Care Conference
PR
24/02US FDA approves Jardianceģ (empagliflozin) to treat adults with heart failure regardles..
PR
23/02ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
AQ
22/02Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Bosto..
PR
18/02Nearly Two-Thirds of Patients Respond to Mirikizumab Treatment at 12 Weeks in Lilly's F..
PR
11/02Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-..
PR
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ELI LILLY AND COMPANY